Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference51 articles.
1. Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy
2. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial
3. Olanzapine versus Placebo and Haloperidol
4. Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review;Brain Sciences;2024-02-28
2. Risperidone vs olanzapine in treatment of schizophrenia: a double blind clinical trial;MOJ Addiction Medicine & Therapy;2018-04-10
3. A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia;Schizophrenia Research and Treatment;2014
4. Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach;PharmacoEconomics;2009
5. Risperidone in adolescent schizophrenic psychoses: A retrospective study;International Journal of Psychiatry in Clinical Practice;2007-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3